What STAGE™ can do for you.
MRI: Head scan
Shorter scan times
30% faster scan times for your most common brain protoclols.
Better MRI data
Increased image clarity with practical access to quantitative data.
Improve the effectiveness and efficiency of the MRI machines you already have, so you can scan more patients per day.
SEE HOW MUCH VALUE SPINTECH MRI CAN HELP YOU GENERATE.
Daily Clinical Value Calculator
Additional reimbursement for your hospital or imaging center running STAGE™.
Number of 3T Scanners
Number of 1.5T Scanners
New Scan Windows/Day:
Improve the patient experience
No one asks to spend more time in an MRI machine. With SpinTech, you can acquire better images in less time. So, patients are happier, and the likelihood of a rescan is greatly reduced.
Standardize data across all your machines
Sharper images, better results
Seamless workflow integration
STAGE™ integrates with your current workflows and equipment, and it’s compatible with most major MRI manufacturers like Siemens, GE and Philips. The software automatically sends processed images back to the PACS, resulting in high-quality, accurate, repeatable results and data outputs compatible across analysis platforms.
ASN 2023: The Arrival of Practical QSM Tools Enhanced for Everyday Clinical Practice
Attendees at this year’s American Society of Neuroimaging annual meeting will have their first opportunity to see and hear how quantitative MRI (qMRI) and quantitative susceptibility mapping (QSM) tools are now practical for – and being used in — everyday clinical practice. QSM is just one of the advanced outputs available with STAGE and is… “ASN 2023: The Arrival of Practical QSM Tools Enhanced for Everyday Clinical Practice”
Health system priorities for AI and two important questions for radiology leaders
A new report from UPMC’s Center for Connected Medicine and KLAS Research about the AI use cases that health systems are prioritizing over the next few years includes findings about plans for radiology AI that raise two important questions for neuroradiologists and healthcare leaders: Based on a survey of 58 executives and senior managers at… “Health system priorities for AI and two important questions for radiology leaders”
STAGE and the Promise and Challenges of New Alzheimer’s Drug Therapies
Radiologists, neurologists, Alzheimer’s patients and their families are rightfully encouraged by the range of new drugs in development to slow or reduce cognitive decline. At the start of 2023 there were 187 trials for 141 drugs addressing Alzheimer’s pathologies. Two drugs, aducanumab and lecanemab, have received accelerated FDA approval in the past two years. A… “STAGE and the Promise and Challenges of New Alzheimer’s Drug Therapies”